News
LANXESS plans to expand capacity for Oxone monopersulfate – a main active ingredient for disinfectants
Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro...
News
Raremark implement a new, dynamic executive team to drive patient-centric drug development in rare diseases
Following accelerated levels of growth over the last six months, Raremark®, the leading rare disease patient network and real-world insights provider has reasserted its commitment to patient-centric drug development by implementing a new, dynamic executive team to drive the...
News
Sobrera Pharma and Recipharm in collaboration to advance a new treatment for patients with Alcohol Use Disorder
Swedish life science company, Sobrera Pharma, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder (AUD).
A phase II...
News
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19
Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®. Captisol®, a Ligand product, is a chemically modified cyclodextrin proven to improve the solubility and stability of drugs. It is...
News
Agilex Biolabs Develops World’s Most Accurate Cannabinoid Assay
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.
The assay is already being used by 4 sponsors in drug development. Agilex Biolabs CEO Jason Valentine...
News
Lantern Pharma Fox Chase Cancer Center Collaborate on Advancing the Development of LP-184 in Pancreatic Cancer
Lantern Pharma , a clinical-stage biopharma company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery & development and identify patients who will benefit from its targeted oncology therapeutics, announced a collaboration and research agreement with...
News
Serum Institute of India starts manufacturing Codagenix’s nasal COVID-19 vaccine
Serum Institute of India has started manufacturing COVID-19 vaccine candidate developed by Codagenix Inc, the US biotech firm said in a statement. Dubbed as CDX-005, the coronavirus vaccine candidate has completed pre-clinical animal studies. The company aims to initiate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read